Metformin use and the risk of incident breast cancer: a systematic review and meta-analysis accounting for…

Effects of Metformin on Clinical Outcomes After Acute Ischemic Stroke in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Ting-Yen Chen, Yu-Chi Su, Yu-Ching Lin
Journal of clinical medicine28 Sep 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Intraspinal abnormalities in MRI-evaluated congenital scoliosis: a systematic review and meta-analysis of prevalence, geographic variation, vertebral anomaly patterns, and Cobb angle.
Nizar Algarni, Khalid Alrasheed, Faisal Alkhunein +3
North American Spine Society journal12 Sep 2026Peer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
Sodium-glucose cotransporter 2 inhibitors vs. glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors for incident and recurrent urolithiasis: a European Association of Urology Endourology systematic review
Arianna Pischetola, Francesco Esperto, Arman Tsaturyan +4
Translational andrology and urology23 Sep 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
History of gastrointestinal symptoms with other glucose‐lowering agents is associated with gastrointestinal adverse events after imeglimin initiation: A retrospective real‐world study
Kodai Yoshida, Yukiko Onishi, Tetsuya Kubota +7
Journal of diabetes investigation23 Oct 2026Peer-reviewedCC BY-NCFull textEndocrinology & metabolismEurope PMC
Treatment outcomes and safety of metformin versus insulin in gestational diabetes mellitus: A systematic review and meta-analysis
Khalid Al-Nemer, Hala Alruwaili, Ayesha Alnashwan +10
Journal of family medicine and primary care1 Jul 2026Peer-reviewedCC BY-NC-NDFull textObstetrics, gynaecology & paediatricsEurope PMCPMC

Cite

BibTeX

@misc{akieda2026metformin,
  title = {{Metformin use and the risk of incident breast cancer: a systematic review and meta-analysis accounting for time-related biases, and why imeglimin cannot yet be evaluated}},
  author = {M. Akieda and Y. Horita and H. Harada and M. Mori and Y. Murata and K. Ohe},
  howpublished = {medRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.01.26367001},
  url = {https://www.medrxiv.org/content/10.64898/2026.11.01.26367001v1},
}

RIS

TY  - UNPB
TI  - Metformin use and the risk of incident breast cancer: a systematic review and meta-analysis accounting for time-related biases, and why imeglimin cannot yet be evaluated
AU  - M. Akieda
AU  - Y. Horita
AU  - H. Harada
AU  - M. Mori
AU  - Y. Murata
AU  - K. Ohe
PY  - 2026
DA  - 2026/11/01
PB  - medRxiv
DO  - 10.64898/2026.11.01.26367001
UR  - https://www.medrxiv.org/content/10.64898/2026.11.01.26367001v1
ER  -

Related

Cite